Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition

Arch Dermatol. 2008 Nov;144(11):1525-6. doi: 10.1001/archderm.144.11.1525.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Chemotherapy, Adjuvant
  • Follow-Up Studies
  • Hair Color / drug effects*
  • Humans
  • Hypopigmentation / chemically induced*
  • Hypopigmentation / physiopathology
  • Ileum / pathology
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Intestinal Neoplasms / genetics
  • Intestinal Neoplasms / therapy
  • Leiomyoma / genetics
  • Leiomyoma / therapy
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / surgery
  • Periodicity
  • Proto-Oncogene Proteins c-kit / drug effects*
  • Proto-Oncogene Proteins c-kit / metabolism
  • Pyrroles / adverse effects*
  • Pyrroles / therapeutic use
  • Risk Assessment
  • Sunitinib
  • Twins, Monozygotic

Substances

  • Indoles
  • Pyrroles
  • Proto-Oncogene Proteins c-kit
  • Sunitinib